Document is current
Any future updates will be listed below
-
Authors
Kühnen, Peter
Wabitsch, Martin
von Schnurbein, Julia
Chirila, Costel
Mallya, Usha G.
Callahan, Patrick
Gnanasakthy, Ari
Poitou, Christine
Krabusch, Philipp M.
Stewart, Murray
Clément, Karine https://orcid.org/0000-0002-2489-3355
- License Information
-
More Information
Article History
Received: 5 October 2021
Accepted: 20 January 2022
First Online: 5 February 2022
Declarations
:
: Both trials were conducted in accordance with the International Council on Harmonisation for Good Clinical Practice and the Declaration of Helsinki. Institutional review board or independent ethics committee approval was obtained at all trial sites. Patients provided informed consent. Patient confidentiality was maintained.
: Not applicable.
: PK has nothing to disclose. MW received compensation as a consultant and for lectures, presentations, speakers bureaus, manuscript writing or educational events. JvS received compensation for lectures, presentations, speakers bureaus, manuscript writing or educational events. CC has nothing to disclose. UGM is an employee of Rhythm Pharmaceuticals and holds stock in the company. PC received compensation as a vendor for his work on this study. AG has nothing to disclose. CP has nothing to disclose. PMK has nothing to disclose. MS is an employee of Rhythm Pharmaceuticals and holds stock in the company. KC has nothing to disclose.
